LFABP regulates the lipid β-oxidation in mammalian liver and intestine and is correlated with various disease conditions including obesity, type 2 diabetes, insulin resistance, and fatty liver disease in humans69,70. This evidence concerns the gene FABP1 and type 2 diabetes mellitus.